跳至主要内容
临床试验/NCT01368744
NCT01368744已完成不适用

Intraoperative Examination of Sentinel Lymph Nodes: Comparison of the OSNA Breast Cancer System to Extensive Frozen Section Histopathology

Sysmex America, Inc.1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2010年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
Prospectively assess the concordance and performance of the OSNA Breast Cancer System with an extensive intraoperative frozen section protocol for SLNs removed using standard SLN biopsy procedures from breast cancer subjects.

研究概览

简要总结

The study will determine the sensitivity, specificity, negative predictive value and positive predictive value of the OSNA Breast Cancer System by comparing its performance to an extensive intraoperative frozen section protocol for Sentinel Lymph Nodes removed during standard Sentinel Lymph Node biopsy procedures from breast cancer subjects.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female;
  • 18 years of age or older;
  • Diagnosed pre-surgically with T1 or T2 breast cancer without clinical evidence of axillary lymph node involvement and scheduled for surgery including sentinel lymph node dissection;
  • Subjects (or the subjects' legal representatives) who have read, understood to the best of their ability and signed the informed consent form.

排除标准

  • Subjects diagnosed pre-surgically with large or locally advanced (T3 & T4) breast cancer;
  • Pregnant subjects, confirmed by interview with either subject or treating physician;
  • Subjects diagnosed with inflammatory breast cancer;
  • Subjects diagnosed with ductal carcinoma in situ (DCIS) when breast conservation is to be done;
  • Subjects with clinically suspicious, palpable axillary lymph nodes;
  • Subjects previously treated for or previously diagnosed with another type of invasive cancer. Subjects with skin cancer (basal cell and squamous cell carcinoma) may be included, except for subjects diagnosed with melanoma; Subjects with non-invasive carcinoma of the Cervix may also be included in this study.
  • Subjects who have received pre-operative systemic therapy;
  • Subjects who are incapable of providing written informed consent;
  • Subjects who have been judged to be an inappropriate candidate by any medical care provider (e.g., surgeon, oncologist or pathologist).
  • Subjects participating in other clinical studies where the SLN evaluation will be negatively impacted by this study.

结局指标

主要结局

Prospectively assess the concordance and performance of the OSNA Breast Cancer System with an extensive intraoperative frozen section protocol for SLNs removed using standard SLN biopsy procedures from breast cancer subjects.

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验